120 related articles for article (PubMed ID: 2683789)
1. Hypertensive dysregulation and its modification by calcium channel blockade in nonoliguric renal failure.
Weidmann P; Schohn D; Gnädinger MP; Bürgisser E; Ferrier C; Jahn H
Am J Nephrol; 1989; 9(4):269-78. PubMed ID: 2683789
[TBL] [Abstract][Full Text] [Related]
2. Norepinephrine-related mechanism in hypertension accompanying renal failure.
Schohn D; Weidmann P; Jahn H; Beretta-Piccoli C
Kidney Int; 1985 Nov; 28(5):814-22. PubMed ID: 4087696
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular regulation during administration of co-dergocrine to normal subjects.
Gerber A; Weidmann P; Laederach K
Eur J Clin Pharmacol; 1986; 29(5):565-72. PubMed ID: 3956562
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of blood pressure in normotensive offspring of hypertensive parents.
Weidmann P; Beretta-Piccoli C
J Cardiovasc Pharmacol; 1988; 12 Suppl 3():S134-48. PubMed ID: 2467099
[TBL] [Abstract][Full Text] [Related]
5. Effects of nitrendipine on blood pressure, renin-angiotensin-system and atrial natriuretic peptide in hypertensive type I diabetic patients.
Lehnert H; Schmitz H; Preuss K; Küstner E; Krause U; Beyer J
Horm Metab Res; 1993 Jan; 25(1):24-8. PubMed ID: 8428706
[TBL] [Abstract][Full Text] [Related]
6. Calcium and blood pressure regulation in normal and hypertensive subjects.
Bianchetti MG; Beretta-Piccoli C; Weidmann P; Link L; Boehringer K; Ferrier C; Morton JJ
Hypertension; 1983; 5(4 Pt 2):II57-65. PubMed ID: 6345376
[TBL] [Abstract][Full Text] [Related]
7. Calcium channel blockade with nitrendipine. Effects on sodium homeostasis, the renin-angiotensin system, and the sympathetic nervous system in humans.
Luft FC; Aronoff GR; Sloan RS; Fineberg NS; Weinberger MH
Hypertension; 1985; 7(3 Pt 1):438-42. PubMed ID: 3158605
[TBL] [Abstract][Full Text] [Related]
8. Altered pressor responses in long-term nitrendipine treatment.
Simon G; Snyder DK
Clin Pharmacol Ther; 1984 Sep; 36(3):315-9. PubMed ID: 6380880
[TBL] [Abstract][Full Text] [Related]
9. Body sodium-blood volume state, aldosterone, and cardiovascular responsiveness after calcium entry blockade with nifedipine.
Marone C; Luisoli S; Bomio F; Beretta-Piccoli C; Bianchetti MG; Weidmann P
Kidney Int; 1985 Oct; 28(4):658-65. PubMed ID: 3910913
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive and hypouricaemic effects of nitrendipine in chronic renal failure.
Weidmann P; Gnädinger MP; Schohn D; Riesen W; Jahn H
Eur J Clin Pharmacol; 1989; 36(3):223-7. PubMed ID: 2744062
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive contribution of sodium depletion and the sympathetic axis during chronic angiotensin II converting enzyme inhibition.
Uehlinger DE; Ferrier CP; Matthieu R; Reuter K; Gnaedinger MP; Saxenhofer H; Shaw S; Weidmann P
J Hypertens; 1989 Nov; 7(11):901-7. PubMed ID: 2558135
[TBL] [Abstract][Full Text] [Related]
12. Pressor factors and cardiovascular pressor responsiveness in lean and overweight normal or hypertensive subjects.
Boehringer K; Beretta-Piccoli C; Weidmann P; Meier A; Ziegler W
Hypertension; 1982; 4(5):697-702. PubMed ID: 7049922
[TBL] [Abstract][Full Text] [Related]
13. Alpha 1-adrenergic blockade and cardiovascular pressor responses in essential hypertension.
Beretta-Piccoli C; Ferrier C; Weidmann P
Hypertension; 1986 May; 8(5):407-14. PubMed ID: 2870984
[TBL] [Abstract][Full Text] [Related]
14. Effects of acute mild hypercalcemia or of the calcium antagonist nifedipine on cardiovascular responsiveness to norepinephrine or angiotensin II in normal humans.
Beretta-Piccoli C; Bianchetti MG; Weidmann P; Boehringer K; Link L; Morton JJ
J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S306-12. PubMed ID: 6184559
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular pressor reactivity after chronic converting enzyme inhibition.
Bernasconi M; Marone C; Beretta-Piccoli C; Lepori G; Shaw S; Weidmann P
Am J Hypertens; 1991 Apr; 4(4 Pt 1):348-55. PubMed ID: 1829371
[TBL] [Abstract][Full Text] [Related]
16. Sympathetic nervous system overactivity in hypertensive patients with chronic renal failure--role of upright body position.
Svarstad E; Myking O; Ofstad J; Iversen BM
Scand J Urol Nephrol; 2001 Oct; 35(5):393-400. PubMed ID: 11771867
[TBL] [Abstract][Full Text] [Related]
17. Potassium and norepinephrine- or angiotensin-mediated pressor control in pre-hypertension.
Bianchetti MG; Weidmann P; Beretta-Piccoli C; Ferrier C
Kidney Int; 1987 Apr; 31(4):956-63. PubMed ID: 3586502
[TBL] [Abstract][Full Text] [Related]
18. Modulation of noradrenergic but not angiotensinergic blood pressure control by beta-blockade with carteolol.
Saxenhofer H; Morger D; Weidmann P; Ferrier C; Shaw SG
J Hypertens; 1991 Nov; 9(11):1049-56. PubMed ID: 1661763
[TBL] [Abstract][Full Text] [Related]
19. Renal effects of nitrendipine monotherapy in essential hypertension.
Thananopavarn C; Golub MS; Eggena P; Barrett JD; Sambhi MP
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1032-6. PubMed ID: 6085362
[TBL] [Abstract][Full Text] [Related]
20. Depressor effects and release of atrial natriuretic peptide during norepinephrine or angiotensin II infusion in man.
Uehlinger DE; Weidmann P; Gnaedinger MP; Shaw S; Lang RE
J Clin Endocrinol Metab; 1986 Sep; 63(3):669-74. PubMed ID: 2942555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
